Dennis L. Cooper

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/814422a0-18ca-11ed-9328-676dda6f2d5c.jpg

First Name

Dennis

Last Name

Cooper

NPI

1154319093

Faculty ID

17301

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

156134

Biography

<p>Dennis L. Cooper, MD, is Chief, Bone Marrow Transplantation and Professor, Medicine at Montefiore Einstein. His clinical focus centers on treating patients with multiple myeloma, hodgkin's lymphoma, non-hodgkin's lymphoma including bone marrow transplantation and CAR T cell therapy.</p><p>After graduating from Loyola University of Chicago in 1975, Dr. Cooper completed his Doctor of Medicine at Rush Medical College in 1979. He then went to Yale-New Haven Hospital to complete his internship and residencies in internal medicine in 1982. Dr. Cooper became Chief Resident in internal medicine at the University of Pittsburgh in 1983, and then participated in a medical oncology fellowship at Yale-New Haven Hospital, completing it in 1985.</p><p>Dr. Cooper&rsquo;s research focuses on clinical trials for multiple myeloma and lymphoma and in the area of bone marrow transplant, he is interested in the use of alternative donor transplants (for patients who don&rsquo;t have a family match) as well as the impact of social determinants of health. Recently, he has published studies involving COVID-19 vaccine responses in patients with plasma cell dyscrasias after complete vaccination, persistent opioid use in patients with multiple myeloma post ASCT and posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants. His work has been published in many peer-reviewed journals and articles.</p><p>Dr. Cooper is a member of the American Society of Hematology and is board certified in Internal Medicine and Medical Oncology. He has won multiple awards, including the Yale Cancer Center Clinical Excellence award from Yale Cancer Center in 2010 and the Vida Award from the Leukemia and Lymphoma Society in 2018.</p>

Is Open Scheduling

Off

Nishi N. Shah

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0f80b160-7e92-11ec-9d5a-db3fba8c54fb.jpg

First Name

Nishi

Last Name

Shah

NPI

1467871756

Faculty ID

17086

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

PubMed.gov URL

EMR ID

2472

Biography

<p>Nishi Shah, MD, MPH, is an attending physician, Oncology, and Assistant Professor at Montefiore-Einstein. Her clinical focus is on the treatment of patients with hematologic malignancies, with particular focus in plasma cell disorders and B-cell malignancies. She utilizes novel targeted agents, stem cell transplant and cell therapies in the treatment of patients.
</p><p>After earning her medical degree at Grand Medical College in Mumbai, India in 2011, Dr. Shah attended the Rollins School of Public Health at Emory University, earning her Master of Public Health in 2014. She then pursued postgraduate training at University of Arkansas for Medical Sciences, completing her internal medicine internship in 2015 and her internal medicine residency in 2017. She then came to Montefiore to pursue a hematology-oncology fellowship, completing it in 2020.
</p><p>Dr. Shah&rsquo;s research focuses on improving access to care and addressing gaps in health equity for patients with hematologic malignancies as well as exploring methods to improve patient access to clinical trials. She has shared her work through peer-reviewed journals, abstracts, and poster presentations. Dr. Shah is also an ad hoc reviewer for several journals including Acta Hematologica, Leukemia and Lymphoma, and Clinical Lymphoma, Myeloma and Leukemia.
</p><p>Dr. Shah is board certified in hematology and medical oncology, and is a member of several professional societies including the American Society of Hematology, the American Society of Clinical Oncology and the Society for Immunotherapy of Cancer. In 2020, she received the Conquer Cancer Merit Award from the American Society of Clinical Oncology.
</p>

Is Open Scheduling

Off

Ioannis Mantzaris

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b67e5d80-3938-11ed-a06a-83625b154202.jpg

First Name

Ioannis

Last Name

Mantzaris

NPI

1871865519

Faculty ID

14586

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

57027

Is Open Scheduling

Off

Noah Kornblum

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0b51dea0-3938-11ed-9b41-f32856b0701a.jpg

First Name

Noah

Last Name

Kornblum

NPI

1053461517

Faculty ID

13153

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Languages

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Non-Hodgkin Lymphoma&nbsp;<br /><br />

Elsevier Profile

EMR ID

4258

Is Open Scheduling

Off

Mendel Goldfinger

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/8c254020-35ce-11ed-8123-8ffce84a9f6a.jpg

First Name

Mendel

Last Name

Goldfinger

NPI

1801174792

Faculty ID

16256

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. William Osler famously said, &ldquo;The good physician treats the disease; the great physician treats the patient who has the disease.&rdquo; I am a strong believer in individualizing treatment plans unique to each patient based on understanding the patient as a whole and the specifics of their disease. I am committed to each patient&rsquo;s care and work hard to ensure that every single patient has the most positive clinical outcome.</p>
<p>I primarily treat people with hematologic malignancies such as Lymphoma, Multiple Myeloma, Leukemia and Bone Marrow diseases. I have a special interest in Chimeric Antigen Receptor T-cell Therapy (CAR T-cell), stem cell transplantation and the use of antibodies to fight cancer. My research focus is in developing novel cellular immunotherapies to target cancer cell antigens. I work with colleagues in our basic science laboratories to discover innovative ways to stimulate an individual patient&rsquo;s immune system to fight cancer and research how to enhance their tumor&rsquo;s immune microenvironment to make their cancer cells more susceptible to immunotherapy. I also have an interest in chemotherapeutic pharmacology and understanding how to precisely target each patient&rsquo;s tumor. Every patient&rsquo;s regimen is tailored by identifying and targeting the tumor&rsquo;s mutation and delivering a therapy based on a precision medicine approach.</p>
<p>I am passionate about giving every patient access to world-class heme malignancies care. The challenge is that some of our best therapies are only available at tertiary level cancer centers like Montefiore which is a long-distance travel for many patients. At the same time, patients benefit from getting their cancer care close to home, in their own community. As director of the Montefiore Hematologic-Malignancy Network, I have worked with our heme malignancy team to develop a Co&mdash;Management Model, where we collaborate with community medical oncologists to enable patients who live far from the Bronx access to novel therapies only available at an NCI designated Cancer Center.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

54204

Is Open Scheduling

Off